Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
BMC Medicine 2015, 13:56 (19 March 2015)
Neville Yeomans comments on a recent consensus statement regarding use of nonsteroidal anti-inflammatory drugs (NSAIDs), and highlights potential side-effects on the whole gastrointestinal tract, and the cardiovascular risks that have yet to be determined.
Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks
BMC Medicine 2015, 13:55 (19 March 2015)
A multidisciplinary group of clinicians provide consensus-based recommendations for prescribing of non-steroidal antiinflammatory drugs (NSAIDs) in patients with osteoarthritis (OA), dependent on individual levels of risk for gastrointestinal and cardiovascular complications.
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
BMC Medicine 2013, 11:46 (21 February 2013)
Gut microbiota are present at lower quantity and have different composition in children with type 1 diabetes compared with healthy children, possibly due to altered gut permeability, and modification of these bacteria could control diabetes development.